FDA Inspection 1255310 — Tadeusz Debniak, MD
The FDA completed an inspection of Tadeusz Debniak, MD on Nov 7, 2024 in Szczecin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 7, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Szczecin (Poland)
Additional Details
Clinical Investigator (CI)